Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.165
-0.025 (-2.10%)
Apr 29, 2026, 12:27 PM EDT - Market open
Actinium Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 48 | 72.9 | 76.68 | 108.91 | 77.83 | Upgrade
|
| Cash & Short-Term Investments | 48 | 72.9 | 76.68 | 108.91 | 77.83 | Upgrade
|
| Cash Growth | -34.16% | -4.92% | -29.60% | 39.93% | 22.45% | Upgrade
|
| Prepaid Expenses | 1.38 | 1.6 | 1.59 | 1.64 | 1.48 | Upgrade
|
| Restricted Cash | - | - | - | 0.4 | 0.39 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.05 | Upgrade
|
| Total Current Assets | 49.38 | 74.51 | 78.26 | 110.94 | 79.75 | Upgrade
|
| Property, Plant & Equipment | 2.06 | 2.07 | 2.87 | 2.95 | 0.64 | Upgrade
|
| Other Long-Term Assets | 0.34 | 0.32 | 0.31 | 0.3 | - | Upgrade
|
| Total Assets | 51.78 | 76.9 | 81.45 | 114.19 | 80.39 | Upgrade
|
| Accounts Payable | 7.25 | 7.57 | 7.95 | 10.13 | 5.54 | Upgrade
|
| Current Portion of Leases | 0.72 | 0.58 | 0.54 | 0.5 | 0.31 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1 | Upgrade
|
| Total Current Liabilities | 7.97 | 8.15 | 8.49 | 10.63 | 6.84 | Upgrade
|
| Long-Term Leases | 0.97 | 0.99 | 1.57 | 2.08 | 0 | Upgrade
|
| Long-Term Unearned Revenue | 35 | 35 | 35 | 35 | - | Upgrade
|
| Total Liabilities | 43.94 | 44.14 | 45.07 | 47.71 | 6.84 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 417.54 | 408.55 | 373.93 | 355.22 | 329.27 | Upgrade
|
| Retained Earnings | -409.71 | -375.83 | -337.58 | -288.77 | -255.75 | Upgrade
|
| Comprehensive Income & Other | -0.02 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 7.83 | 32.76 | 36.38 | 66.48 | 73.55 | Upgrade
|
| Total Liabilities & Equity | 51.78 | 76.9 | 81.45 | 114.19 | 80.39 | Upgrade
|
| Total Debt | 1.69 | 1.57 | 2.11 | 2.58 | 0.31 | Upgrade
|
| Net Cash (Debt) | 46.3 | 71.33 | 74.56 | 106.33 | 77.52 | Upgrade
|
| Net Cash Growth | -35.09% | -4.34% | -29.87% | 37.16% | 23.39% | Upgrade
|
| Net Cash Per Share | 1.48 | 2.37 | 2.80 | 4.40 | 3.77 | Upgrade
|
| Filing Date Shares Outstanding | 31.18 | 31.2 | 29.4 | 25.73 | 22.14 | Upgrade
|
| Total Common Shares Outstanding | 31.2 | 31.2 | 27.63 | 25.67 | 22.14 | Upgrade
|
| Working Capital | 41.41 | 66.36 | 69.77 | 100.31 | 72.91 | Upgrade
|
| Book Value Per Share | 0.25 | 1.05 | 1.32 | 2.59 | 3.32 | Upgrade
|
| Tangible Book Value | 7.83 | 32.76 | 36.38 | 66.48 | 73.55 | Upgrade
|
| Tangible Book Value Per Share | 0.25 | 1.05 | 1.32 | 2.59 | 3.32 | Upgrade
|
| Machinery | 1.26 | 1.26 | 1.24 | 1.09 | 0.68 | Upgrade
|
| Construction In Progress | 0.1 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.